TRIESTE, LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 8.236
EU - Europa 5.729
AS - Asia 4.660
SA - Sud America 898
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 123
OC - Oceania 43
Totale 19.826
Nazione #
US - Stati Uniti d'America 7.859
IT - Italia 1.951
SG - Singapore 1.714
RU - Federazione Russa 1.195
CN - Cina 1.146
GB - Regno Unito 737
BR - Brasile 690
VN - Vietnam 632
DE - Germania 444
UA - Ucraina 286
CA - Canada 259
HK - Hong Kong 235
BD - Bangladesh 218
FR - Francia 190
KR - Corea 162
DK - Danimarca 148
SE - Svezia 143
IN - India 138
NL - Olanda 116
FI - Finlandia 95
PL - Polonia 83
AR - Argentina 79
IE - Irlanda 74
MX - Messico 63
ES - Italia 60
JP - Giappone 58
TR - Turchia 56
ID - Indonesia 47
ZA - Sudafrica 47
EC - Ecuador 42
AU - Australia 38
BE - Belgio 34
PH - Filippine 34
IQ - Iraq 32
AT - Austria 30
PK - Pakistan 30
CO - Colombia 26
MY - Malesia 24
PT - Portogallo 24
CH - Svizzera 21
EU - Europa 20
IL - Israele 20
TW - Taiwan 19
LT - Lituania 15
TN - Tunisia 15
MA - Marocco 14
PY - Paraguay 14
RO - Romania 14
VE - Venezuela 13
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 12
UZ - Uzbekistan 12
CL - Cile 11
JO - Giordania 11
PE - Perù 11
JM - Giamaica 10
KE - Kenya 9
AZ - Azerbaigian 7
CR - Costa Rica 7
HN - Honduras 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
EG - Egitto 6
GR - Grecia 6
LV - Lettonia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
IR - Iran 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
SI - Slovenia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
GT - Guatemala 3
NG - Nigeria 3
PS - Palestinian Territory 3
SR - Suriname 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
Totale 19.682
Città #
Dallas 1.866
Singapore 927
Ashburn 574
San Jose 515
Beijing 423
Chandler 375
Woodbridge 342
Southend 341
Houston 270
Milan 248
Council Bluffs 243
Pisa 220
Hong Kong 218
Moscow 185
Rome 177
San Mateo 175
Ho Chi Minh City 172
Ann Arbor 170
Los Angeles 165
The Dalles 156
New York 149
Jacksonville 142
Fairfield 123
Hanoi 123
Dearborn 105
Seattle 101
Santa Clara 98
Daejeon 97
Cambridge 90
Wilmington 90
Boardman 89
Falls Church 87
São Paulo 82
Hefei 77
Beauharnois 70
Lauterbourg 69
Dublin 67
Warsaw 67
Dong Ket 65
Seoul 62
Stevenage 61
Portsmouth 59
Buffalo 57
Montreal 57
Lawrence 55
Orem 54
Brooklyn 53
Florence 51
Fremont 49
Denver 48
London 43
Tokyo 43
Atlanta 42
Chennai 42
Phoenix 42
Munich 41
Stockholm 38
Salerno 37
Bologna 34
Figino 33
Helsinki 33
Columbus 32
Johannesburg 31
Serra 31
Chicago 30
Poplar 30
Mexico City 29
Frankfurt am Main 28
Haiphong 28
Paris 27
Genoa 26
Buti 25
Montréal 25
Amsterdam 24
Toronto 24
Turin 24
Redwood City 23
Ankara 22
Naples 22
Old Bridge 21
Boston 20
Lucca 20
Nuremberg 20
Ottawa 20
Rio de Janeiro 20
San Francisco 18
Mumbai 17
Trento 17
Da Nang 16
Quito 16
Charlotte 15
Dhaka 15
Guayaquil 15
Livorno 15
Querétaro 15
Vienna 15
Hamburg 14
Istanbul 14
Manchester 14
Tel Aviv 14
Totale 11.419
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 803
On Robots and Insurance 579
The Effect of using Serifs in Brand Names on Luxury Perception 547
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 519
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 422
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 400
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 384
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 374
How colour saturation accelerates purchase behaviour, and influences food choice: 337
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 334
A systematic literature review of the economic impact of ankylosing spondylitis 322
Is EEG Suitable for Marketing Research? A Systematic Review 308
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 300
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 300
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 299
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 299
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 296
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 290
Natural and man-made disasters: challenges and international perspectives for insurance 288
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 287
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 283
Assessing the value of the use of diagnostic technology: trade offs for GPs 282
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 275
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 270
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 270
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 268
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 266
Columbus' egg and the engineer's effect in forecasting solutions adoption 266
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 264
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 264
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 263
Health information technologies in systemic lupus erythematosus: focus on patient assessment 261
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 259
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 259
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 258
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 251
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 250
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 249
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 248
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 240
Management and Treatment of Type 1 And 2 Diabetes: State of Art 239
Systemic vasculitis: how little we know about their societal and economic burden 238
Consideration on the Accuracy of Watch for Physical Activity Tracker 228
Raiders of Lost Value 227
The definition of a new organizational, technology-based, integrated home care model 225
The nature, causes, and effects of skepticism on technology diffusion 224
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 223
Razionale e strumenti della valutazione economica in sanità 220
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 218
The economic impact of gout: a systematic literature review 217
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 216
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 214
Food literacy and food purchase behaviour 214
Natura e ruolo degli indicatori nella logistica farmaceutica 205
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 201
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 187
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 186
Analysis and Synthesis in Information Processing and Knowledge Creation 184
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 183
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 182
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 179
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 178
Valutazione dei risultati di una gara 176
Finanziamenti pubblici 171
EYE ON PACK. Visual search strategies in food choice 168
Le start up 166
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 165
Strumenti per favorire gli investimenti e la competitività delle imprese 161
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 160
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 157
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 156
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 149
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 142
Industria 4.0 e Digitalizzazione 126
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 124
Nonlinear trade-offs in customer acquisition and retention 90
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 67
null 63
Identifying needs in adult rehabilitation to support the clinical implementation of robotics and allied technologies: an Italian national survey 26
The Role of Digital Tools and Their Implementation Within Patient Care Pathways for Rare Brain Disorders: The Case of Phenylketonuria 24
null 13
Totale 19.826
Categoria #
all - tutte 88.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 0 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20269.638 504 1.192 1.623 1.203 1.001 594 1.003 405 503 560 391 659
2026/2027679 256 303 120 0 0 0 0 0 0 0 0 0
Totale 19.826